Načítá se...
Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy
Abstract Background Retinopathy of prematurity (ROP) remains a major cause of childhood blindness and current laser photocoagulation and anti-VEGF antibody treatments are associated with reduced peripheral vision and possible delayed development of retinal vasculatures and neurons. In this study, we...
Uloženo v:
Hlavní autoři: | , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BMC
2018-07-01
|
Edice: | Molecular Medicine |
Témata: | |
On-line přístup: | http://link.springer.com/article/10.1186/s10020-018-0038-1 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|